Patents by Inventor Wanjun GUO

Wanjun GUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230330189
    Abstract: Provided are a GLP-1(7-37) polypeptide analogue, a fatty acid-modified derivative of the analogue, and a medicament comprising the derivative. Further, also provided are a preparation method of the derivative, and use of the same in the preparation of a medicament.
    Type: Application
    Filed: March 17, 2023
    Publication date: October 19, 2023
    Applicant: Sciwind Biosciences Co., Ltd.
    Inventors: Zheng XU, Feng LI, Rui SONG, Wanjun GUO, Hai PAN, Jing FENG
  • Patent number: 11766665
    Abstract: Disclosed is a method for efficiently synthesizing primary amines, which comprises using carbonyl compounds or alcohol compounds as reaction substrate, liquid ammonia or alcohol solutions of ammonia as nitrogen source, and hydrogen as hydrogen source, and reacting in reaction medium catalyzed by a cobalt-based catalyst to obtain the primary amines. Due to high catalytic activity, the method can realize the reductive amination of carbonyl compounds and the hydrogen-borrowing amination of alcohol compounds at low temperatures in a short time to obtain the primary amines with high yield, and is applicable to a wide range of substrates. The obtained primary amines can be used as raw materials with high extra value for producing polymers, medicines, dyes and surfactants. Further, the cobalt-based catalyst has a good industrial application prospect because it is magnetic which can facilitate separation and recycling of the catalyst.
    Type: Grant
    Filed: December 28, 2021
    Date of Patent: September 26, 2023
    Assignee: East China University of Science and Technology
    Inventors: Yanqin Wang, Wanjun Guo, Shuang Xiang, Xiaohui Liu, Yong Guo
  • Publication number: 20230265144
    Abstract: Provided are an interleukin 29 (IL29) mutant protein, and a fusion protein, a conjugate, a pharmaceutical composition, a product and a kit which comprises the mutant protein. The provided IL29 mutant protein has good activity and stability, and can effectively prevent and/or treat viral infectious diseases, tumors and other diseases needing to regulate the body immune function.
    Type: Application
    Filed: February 8, 2021
    Publication date: August 24, 2023
    Applicant: SCIWIND BIOSCIENCES CO., LTD.
    Inventors: Liu YANG, Yan LI, Jing FENG, Wanjun GUO, Hai PAN
  • Publication number: 20230102416
    Abstract: Disclosed is a method for efficiently synthesizing primary amines, which comprises using carbonyl compounds or alcohol compounds as reaction substrate, liquid ammonia or alcohol solutions of ammonia as nitrogen source, and hydrogen as hydrogen source, and reacting in reaction medium catalyzed by a cobalt-based catalyst to obtain the primary amines. Due to high catalytic activity, the method can realize the reductive amination of carbonyl compounds and the hydrogen-borrowing amination of alcohol compounds at low temperatures in a short time to obtain the primary amines with high yield, and is applicable to a wide range of substrates. The obtained primary amines can be used as raw materials with high extra value for producing polymers, medicines, dyes and surfactants. Further, the cobalt-based catalyst has a good industrial application prospect because it is magnetic which can facilitate separation and recycling of the catalyst.
    Type: Application
    Filed: December 28, 2021
    Publication date: March 30, 2023
    Applicant: East China University of Science and Technology
    Inventors: Yanqin WANG, Wanjun GUO, Shuang XIANG, Xiaohui LIU, Yong GUO
  • Patent number: 11612640
    Abstract: Provided are a GLP-1(7-37) polypeptide analogue, a fatty acid-modified derivative of the analogue, and a medicament comprising the derivative. Further, also provided are a preparation method of the derivative, and use of the same in the preparation of a medicament.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: March 28, 2023
    Assignee: SCIWIND BIOSCIENCES CO., LTD.
    Inventors: Zheng Xu, Feng Li, Rui Song, Wanjun Guo, Hai Pan, Jing Feng
  • Publication number: 20210393744
    Abstract: Provided are a GLP-1(7-37) polypeptide analogue, a fatty acid-modified derivative of the analogue, and a medicament comprising the derivative. Further, also provided are a preparation method of the derivative, and use of the same in the preparation of a medicament.
    Type: Application
    Filed: April 19, 2019
    Publication date: December 23, 2021
    Applicant: SCIWIND BIOSCIENCES CO., LTD.
    Inventors: Zheng XU, Feng LI, Rui SONG, Wanjun GUO, Hai PAN, Jing FENG